Houston innovators podcast episode 41

With increased awareness in need for connected medical devices, this Houston startup fills the gap

Chris Dupont, CEO of Galen Data, has seen his share of challenges and opportunities amid the COVID-19 pandemic. Photo via galendata.com

For decades, medical device innovation has been improving the way patients are cared for, but only recently are innovators enabling important connectivity applications.

"Most legacy medical devices are not connected to the internet," says Chris DuPont, CEO and founder of Galen Data Inc. "All the new companies that are coming to us — the emerging wearable tech — connectivity is vital in their product roll out."

But with this internet connectivity, adhering to safety regulations adds costly and challenging obstacles for medical device companies. That's where Galen Data comes into play, and the Houston startup is seeing more of a need for its medical device cloud services now more than ever.

"COVID-19 has created all kinds of challenges — and I think in the long run, a lot of opportunities for Galen," DuPont shares on this week's episode of the Houston Innovators Podcast. "I think there will be a heightened awareness for the need for connected medical devices."

Galen Data's technology enables better communication between the device, the patient, and the medical provider, and DuPont equates it to being able to have a system similar to a check engine light on your vehicle.

"Wouldn't you want to know if your drug pump was starting to have problems or if the electro mechanical systems were starting to fail?" DuPont asks on the podcast.

The company's technology also provides important medical data and information that can be crucial for detecting trends and predictability.

"There's far greater risk in not having access to certain critical data to that device," DuPont says when asked about the hesitation some people have regarding medical data in terms of privacy.

DuPont shares more about his company's recent growth, his most recent partnership with an Austin-based medical device company, and how he's observed Houston emerging medical device innovation ecosystem evolve over his decades of experience. Listen to the full interview below — or wherever you get your podcasts — and subscribe for weekly episodes.


Trending News

Building Houston

 
 

Houston Exponential has a released a report that found that Houston tech companies have seen a 7 percent year-over-year increase in venture capital investments so far in 2020. Getty Images

This year might be a wash for a lot of things, but according to a new fundraising report from Houston Exponential, the Bayou City has seen an increase in funding this year compared to 2019.

The HTX Funding Review found that Houston startups raised $466.33 million across 46 deals between January and July — compared to $437 in the same time frame last year. While the increase seems marginal, it's important to consider the effect of the pandemic and the few months of troubles for the oil and gas industry.

The 7 percent increase in funding is impressive compared to the national average of 2.5 percent, according to the report, which was organized by Serafina Lalany, HX chief of staff. Eighteen later stage deals made up for 76 percent of the total money raised, indicating key growth for the ecosystem.

"This expansion in Houston's relatively new and booming tech innovation ecosystem shows a strength and resilience that is really exciting," says Harvin Moore, president of HX, in the report. "We are seeing a maturation of our very young ecosystem, as rapidly growing tech companies increasingly access later stage venture capital, which often comes from outside the local area."

The report calls out 11 deals — ranging from angel to late stage — that have occured in Houston to date in 2020:

  • Preventice Solutions, a medical device company, raised a $137 million series B led by Palo Alto-based Vivo Capital along with support from existing investors, including Merck Global Health Innovation Fund, Boston Scientific, and the Samsung Catalyst Fund.
  • Fintech and software-as-a-service company HighRadius raised a $125 million series B led by ICONIQ Capital, with participation from existing investors Susquehanna Growth Equity and Citi Ventures.
  • Liongard, a SaaS company, raised a $17 million series B led by TDF Ventures, Integr8d Capital, and private investors.
  • Base Hologram, a provider of hologram concert experience, raised $15.4 million in an outsized angel round this past May.
  • ThoughtTrace, another SaaS company, raised $10 million in a series B led by McRock Capital and existing investors, as well as Chevron Technology Ventures.
  • Renewable energy company Quidnet also raised a $10 million series B. Bill Gates-backed Breakthrough Energy Ventures and Canada-based Evok Innovations, which both previously invested in the company, contributed to the round.
  • SmartAC.com emerged from stealth mode with a $10 million series A fundraising announcement.
  • Retina AI, an AI company focused on diagnostics for diseases such as diabetic retinopathy from pictures of the retina, raised $4.1 million in an angel round which closed mid-July.
  • E-commerce platform Goodfair raised $3.67 million from but the round was led by Imaginary, with support from MaC Venture Capital, Global Founders Capital, Willow Ventures, Watertower, Amplify.LA, Capital Factory, and Texas Ventures.
  • SecurityGate, a cybersecurity platform, raised funds from Houston Ventures in June, but wouldn't disclose how much.
  • Oil and gas software company, M1neral, raised $1.6 million pre-seed co-led by Amnis Ventures and Pheasant Energy, among a few other select investors and strategic partners.

While the pandemic has made funding and vetting new portfolio companies, Blair Garrou, managing director of Houston-based Mercury Fund, says venture capital firms are committed to backing the strongest startups already in their portfolio.

"We've seen many VCs focus on a 'flight to quality,'" Garrou says. "Specifically, VCs are focused more on making sure their best performing portfolio companies have cash, especially at the later stages, as well as investing in the later rounds of new deals that are clear over-performers during COVID."

Looking forward, the HX report predicts that fundraising growth will continue throughout the rest of the year.

"There are several very large local deals in final term sheet stage, and we expect full year 2020 to be the highest ever for venture capital in Houston; our ecosystem is really thriving," says Moore in the report.

Trending News